• SENSEX 72,781.89
    -251.89 (--0.34%)
  • BANKNIFTY 55,316.00
    -165.05 (--0.30%)
  • JSW Steel
    1,158.95 1,072.90(%)
  • NSE
    1,780.00 1,878.00(%)
  • SS Retail
    828.30 888.00(%)
  • Infosys
    1,095.90 1,727.85(%)
  • T R I L
    360.95 495.80(%)
  • Max Healthcare
    850.10 843.00(%)
  • IndusInd Bank
    866.00 725.90(%)
  • Cholaman.Inv.&Fn
    1,553.00 1,299.80(%)
  • Life Insurance
    391.35 361.00(%)
  • Reliance Industries
    1,187.90 1,611.20(%)
  • Tata Elxsi
    3,706.00 5,949.95(%)
  • Meesho
    226.45 125.70(%)
  • Elecon Engg.Co
    501.05 579.95(%)
  • HDFC Bank
    708.00 682.00(%)
  • TCS
    2,335.45 3,336.70(%)
  • MV Electrosystems
    999.00 999.00(%)
  • Voltas
    1,050.75 1,582.00(%)
  • Go Digit General
    284.75 373.40(%)
  • Hero Motors
    167.50 179.00(%)
  • B H E L
    463.60 463.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
2,157.70 31 (1.44%)
  • As on 14 Oct 2026 (EOD)

  • Today’s Low

    2,112.70

  • Today’s High

    2,189.90

  • Open

    2,123.30

  • Perv Close

    2,127.00

  • 52W Low

    1,239.30

  • 52W High

    2,683.60

Key Indicators

  • P/E(TTM)

    34.03

  • Mar.Cap (₹Cr.)

    1,835.53

  • Div & Yield %

    0.51

  • Book Value(₹)

    452.79

  • Debt-Equity Ratio

    1.44

  • AGM Date

    14-Oct-2026

  • EPS

    63.10

  • P/E Ratio

    34.03

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,835.53

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    452.80

  • Sales( ₹ in Cr.)

    292.14

  • NP (in Cr.)

    47.02

  • NP Var(%)

    46.0

  • Div%

    110.0

  • CPS (₹)

    67.30

  • EPS (₹)

    55.30

  • Traded Value (₹ in Lakhs)

    1,826.59

  • 52 Week High

    2,683.60

  • 52 Week Low

    1,239.30

  • Price BSE

    2147.0

  • Price NSE

    2,158.00

  • Market Capital( in Cr.)

    1,826.59

  • P/C Ratio

    31.90

  • P/E Ratio

    38.80

  • Price Vs.BV

    55.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 292.14 286.47 285.16 254.00 219.35 208.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 292.14 286.47 285.16 254.00 219.35 208.48
Other Income 14.63 4.76 4.26 5.32 4.66 1.65
Stock Adjustments 3.69 -9.97 -10.36 4.77 12.53 -4.01
Total Income 310.46 281.26 279.06 264.09 236.54 206.12
EXPENDITURE :            
Raw Materials 85.66 83.70 89.28 84.65 76.37 49.38
Power and Fuel Cost 9.20 10.12 12.34 9.95 8.74 6.93
Employee Cost 53.17 54.76 56.72 47.92 39.12 33.45
Other Manufacturing Expenses 15.23 14.07 14.49 7.57 6.89 5.46
Selling and Administration Expenses 49.88 54.45 50.25 49.26 34.94 32.24
Miscellaneous Expenses 10.21 8.46 4.37 4.55 5.26 10.28
Employee Benefit Expenses 53.17 54.76 56.72 47.92 39.12 33.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 223.36 225.56 227.45 203.88 171.31 137.74
Operating Profit 87.10 55.71 51.60 60.21 65.23 68.37
Interest 7.17 5.37 5.09 6.50 2.47 3.95
Gross Profit 79.93 50.34 46.51 53.71 62.76 64.42
Depreciation 10.25 8.58 9.78 9.79 9.50 9.63
Profit Before Tax 69.68 41.76 36.73 43.92 53.26 54.79
Current Tax 14.47 11.27 9.64 10.73 14.25 16.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.12 -1.35 -0.06 0.86 -0.51 -1.48
Reported Net Profit 52.10 31.84 27.16 32.34 39.52 39.90
Extraordinary Items 5.08 -0.35 0.02 0.01 0.09 -3.69
Adjusted Net Profit 47.02 32.19 27.14 32.33 39.43 43.59
Adjustment below Net Profit -0.05 -0.36 -0.02 0.11 -0.16 0.21
P & L Balance brought forward 272.91 246.53 226.20 202.25 171.40 136.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 5.96 5.10 6.81 8.51 8.51 5.62
P & L Balance carried down 319.00 272.91 246.53 226.20 202.25 171.40
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 110.00 70.00 60.00 80.00 100.00 100.00
Dividend Per Share(Rs) 11.00 7.00 6.00 8.00 10.00 10.00
Earnings Per Share-Unit Curr 61.24 37.43 31.93 38.02 46.45 46.90
Earnings Per Share(Adj)-Unit Curr 61.24 37.43 31.93 38.02 46.45 46.90
Book Value 452.78 398.60 367.59 343.70 315.54 279.28
Book Value(Adj)-Unit Curr 452.78 398.60 367.59 343.70 315.54 279.28

Shareholding Pattern

  • Promoter Group

    44.28%

  • Public Share Holding

    55.72%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 336,838 3.96 336,838 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,002 0.31 26,002 17
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 157 0.00 157 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,050 0.08 7,050 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 33,209 0.39 33,209 20
2] Non Institution
Bodies Corporate 289,086 3.40 289,085 117
Clearing Members 52,732 0.62 52,732 12
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,312,717 15.43 1,312,717 426
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 172,925 2.03 172,925 322
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,274,018 14.98 1,274,018 17
Individuals holding nominal share capital up to Rs. 1 lakh 1,507,303 17.72 1,457,647 10,749
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,499 0.03 2,499 1
Others 92,041 1.08 92,041 2
Sub Total 4,706,667 55.33 4,657,010 11,654
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,457,208 11,685

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

  • Company Secretary

    Vinod Mali

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 2,147.20 299.77 292.14 30.98 15.28
Abbott India 26,346.00 7,217.19 6,929.05 34.67 43.78
Astrazeneca Phar 5,943.50 2,304.07 2,275.58 87.60 27.86
Glaxosmi. Pharma 2,539.40 3,932.76 3,790.20 40.57 58.17
Novartis India 1,988.85 393.10 354.33 50.22 15.94
Cipla 1,312.85 20,102.60 18,979.95 34.50 13.88
Bliss GVS Pharma 661.10 773.53 729.81 61.44 12.51
Amrutanjan Healt 503.10 520.13 502.55 26.95 24.16
Fermenta Biotec. 499.90 474.15 450.25 23.34 18.77
Guj. Themis Bio. 392.05 168.25 165.82 104.83 18.05
Ambalal Sarabhai 38.95 19.52 3.94 72.13 6.77